CORCEPT THERAPEUTICS INC
Develops and commercializes cortisol-modulating medications for severe disorders.
CORT | US
Overview
Corporate Details
- ISIN(s):
- US2183521028
- LEI:
- Country:
- United States of America
- Address:
- 101 REDWOOD SHORES PARKWAY, 94065 REDWOOD CITY
- Website:
- https://www.corcept.com/
- Sector:
- Manufacturing
Description
Corcept Therapeutics Inc. is a commercial-stage pharmaceutical company engaged in the discovery, development, and commercialization of medications. The company focuses on cortisol modulation, developing molecules that regulate cortisol activity at the glucocorticoid receptor (GR). Its primary mission is to create novel treatments for severe disorders. Corcept's research and development efforts span multiple therapeutic areas, including endocrinology, oncology, metabolism, and neurology, aiming to address serious diseases impacted by cortisol.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CORCEPT THERAPEUTICS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CORCEPT THERAPEUTICS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CORCEPT THERAPEUTICS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
